​​​​​

Photobiomodulation Equipment and Training - THOR Photomedicine

Select Region

Information contained on this page may not be appropriate for your region, please select your region from below. To navigate back to this region selector, please click "Region" in the footer.
Do More With A THOR
Lots of happy THOR customer testimonials
NovoTHOR Whole Body Light Pod

Photobiomodulation relief for neck pain

LASER for neck pain

Systematic review with meta-analysis published by The Lancet

A clinical trial published in the journal PAIN and

acknowledged by the World Health Organisation

NOTE: Treatment videos below and an audio interview to the right.

Results from the recent Lancet review of Low level laser Therapy for chronic neck pain.

The Lancet report declares that neck pain is approaching epidemic proportions with 10 - 24% of the population affected. Musculoskeletal diseases, which include back pain, arthritis, bodily injuries, and osteoporosis, are reported by persons in the U.S. more than any other health condition. In 2004, the estimated total cost of treatment and lost wages associated with musculoskeletal diseases was $849 billion, equal to 7.7 percent of the gross domestic product (GDP):
Spine: Low Back and Neck Pain
The Burden of Musculoskeletal Diseases

The paper also reports that pharmacological therapies for neck pain are widely used but have "not shown any conclusive evidence of benefit" The BMJ agrees "There isn't any specific research that shows drugs help neck pain". There is now more evidence for the use of laser for neck pain than any other medical procedure. The Lancet report says "(Relief using) Laser for neck pain lasted for up to 22 weeks. Trials of PBM for knee osteoarthritis tendinopathies and low back pain reported similar results". "This contrasts with drug therapies where the effect ends rapidly when treatment is discontinued."

BRIEF SUMMARY OF LASER STUDIES REVIEWED FOR THE LANCET:

  • 16 RCT's of acceptable methodological quality
  • Mean duration of symptoms 7.5 years +/-36.9 months
  • Mean baseline of pain intensity 56.9mm +/-7.5mm

RESULTS:

  • Reduce pain intensity
  • Reduced disability
  • Reduces recurrence of acute neck pain
  • Mean Pain intensity reduction over placebo 20mm (95%CI: 17.1 to 29.8 @ 10-22 weeks)

COMMENT:

This establishes PBM as an evidence based treatment for neck pain. It is at least equivalent to and probably better than other accepted medical treatments for neck pain.

WHAT IS PBM AND HOW DOES IT WORK ON NECK PAIN:

A gentle beam of laser light can stimulate cells to repair tissues, reduce inflammation and inhibit pain fibres to reduce pain. The application of specific wavelengths of red or near infrared laser or LED light on acute injuries and degenerative conditions relieves pain and improves healing. There are two main mechanisms:

  • At low doses it acts on mitochondrial proteins to reduce oxidative stress and increase production of ATP.
  • At high doses it inhibits fast axonal flow in C and A delta fibres causing a temporary neural blockade, reducing central sensitisation.

HOW LONG IS A TREATMENT SESSION:

Treatment sessions: after initial consultation, actual therapy time takes typically 15 to 20 minutes.

HOW SOON DOES IT START TO WORK:

Patients typically experience improvement (reduction in pain / greater range of movement) immediately after the first treatment.

HOW MANY TREATMENTS DOES IT TAKE:

It can take as much as a dozen sessions but sometimes as few as three.

HOW OFTEN SHOULD PATIENTS COME FOR TREATMENT:

Twice a week for the first two weeks then once a week for a further two weeks.

HOW LONG DO THE BENEFITS LAST:

In most cases, once an acute episode is over, patients are unlikely to need further treatment. For a few people, the benefit may only be temporary - they may need long term maintenance every 6 - 8 weeks.

ADVANTAGES OVER DRUG THERAPIES

The evidence for PBM is much stronger than for drug therapies. There are no analgesics or anti-inflammatories licensed for the treatment of neck pain. PBM also has the advantage of having no side effects, unlike many drug therapies.

PBM NECK PAIN TREATMENT VIDEO

TV INTERVIEW WITH DR ROBERTA CHOW

EQUIPMENT AND TRAINING:

To contact your local dealer for THOR laser systems CLICK HERE.

For training course information CLICK HERE

LX2 table top control unit

THOR:

With over 5,000 customers using THOR equipment in 70 countries including Harvard Medical School, NASA researchers, US Navy, RAF, British Army, Royal Navy, NHS, BUPA, premier division football teams, British Lions Rugby, THOR can rightly claim to be the number one supplier of PBM technology and training.

Published in the worlds top scientific medical journals

Published in the worlds top scientific medical journals

Over 700 randomised clinical trials and 3,000 laboratory trials.


Dr Roberta Chow Interview

Listen here

Or download sound file
Audio length: 24:35
Dr Chow has given this interview freely to advance the understanding of low level laser therapy in neck pain. This in no way implies a specific endorsement of THOR Photomedicine.

Product information and purchase enquiry

Sorry for the long form.

We are a global company and our computer needs to know who to direct your enquiry to.

* Mandatory field - this automatically directs your enquiry to the correct department

Sign up to our PBM monthly newsletter Low Level Laser Therapy relief for chronic neck pain



OUR CUSTOMERS INCLUDE:
Our customers include: Harvard Medical School, Massachusetts General Hospital, British Army, RAF, Royal Navy, Team GB, Manchester United, MIT, Harvard School of Public Health, Cedars Sinai, City of Hope, USUHS
THOR Customers

THOR Photomedicine Ltd is an ISO 13485:2016 certified medical device company.

The THOR LX2.3 Photobiomodulation system has a medical CE mark (EC certificate). It is indicated for oral mucositis, tendinopathies, joint pain, neck pain and back pain for marketing in the UK, EU and Australia.

The THOR LX2.3 Photobiomodulation system is also FDA Cleared for marketing in the United States for: Temporary increase in local blood circulation, temporary relief of minor muscle and joint aches, pains and stiffness and relaxation of muscles; for muscle spasms, and minor pain and stiffness associated with arthritis.

Excluding the THOR LED Helmet, THOR LX2 and NovoTHOR systems are manufactured under conditions fulfilling the quality system requirements of Annex II, excluding (4), of the directive 93/42/EEC as amended and satisfy the applicable international harmonised standards.

Positive systematic reviews published by:

The British Medical Journal (BMJ), The Lancet, the International Association for the Study of Pain (IASP), the World Health Organisation (WHO), the Multinational Association for Supportive Care in Cancer (MASCC), the European Society for Medical Oncology (ESMO)

Appropriate regulatory clearance or approvals include:

Quality certificates

​​​​​